Aripiprazole in treatment of schizophrenia and bipolar disorder

Abstract

Aripiprazole, a partial dopamine agonist, is approved for treatment of schizophrenia, acute manic episodes a in maintenance treatment for relapse prevention of manic episodes.Aripiprazole treatment is associated with a relatively low risk of adverse events and good subjective well-being of patients.

Keywords

• aripiprazole
• schizophrenia
• bipolar disorder
• subjective well-being